Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 234 across all filing types
Latest filing 2025-02-22 Regulatory Filings
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian NI 52-109 for venture issuers, comprised solely of a CEO’s certification regarding the interim financial report and interim MD&A for the quarter ended December 31, 2024. It is not the interim report or MD&A itself, nor an announcement of a new report; rather it is a regulatory compliance form. No specific category exists for certification forms, so it falls under the fallback “Regulatory Filings” (RNS).
2025-02-22 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian NI 52-109, signed by the CFO, certifying the interim financial report and MD&A for the period ended December 31, 2024. It is neither the interim report itself (which would be classified as an Interim/Quarterly Report, IR) nor simply an announcement that the report has been published (RPA). Instead, it is a mandatory regulatory certificate filing. It does not fit into any other specialized category, so the correct classification is as a general Regulatory Filing (RNS).
2025-02-22 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is clearly a Management Discussion & Analysis (MD&A) covering the three months ended December 31, 2024, discussing operational results, liquidity, IFRS compliance, and forward‐looking statements. It is not an announcement or earnings release but the full MD&A narrative accompanying an interim period. According to the filing definitions, this aligns with “Management Reports” (Code: MDA).
2025-02-22 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS' for the three months ended December 31, 2024. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flow) along with detailed notes to the financial statements. It is not an announcement or a certification, but the actual financial report for an interim period. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-02-22 English
News release - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of Special Meeting of Shareholders, including details on the meeting agenda, record date, proxy voting instructions, and reference to accompanying management information circular and proxy form. This notice is part of the proxy solicitation materials sent to shareholders to provide information and request votes for the meeting, matching the definition of a Proxy Solicitation & Information Statement (PSI).
2025-02-19 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a standard press release announcing NetraMark’s upcoming presentations at an industry scientific meeting, with background on the company and forward-looking statements. It does not contain financial results (ER, IR), management discussion (MDA), governance details (CGR), notice of dividends (DIV), M&A (TAR), or other specific regulatory filings. It is not an actual investor slide deck (IP) nor a formal regulatory form. Thus, it falls into the fallback “Regulatory Filings” category for miscellaneous announcements.
2025-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.